Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Template:Current week ecosystem agenda"

From Bioblast
Line 13: Line 13:
- communicated by »[[Cardoso Luiza]]« and »[[Grings Mateus]]«
- communicated by »[[Cardoso Luiza]]« and »[[Grings Mateus]]«
|}
|}
----
----
*'''Aug- 23 We'''
*'''Aug- 23 We'''
----
----
*'''Aug- 24 Th'''
*'''Aug- 24 Th'''
----
:{|
:{|
| width="100" align="center" |[[File:FAT4BRAIN logo.png|80px|link=https://wiki.oroboros.at/index.php/FAT4BRAIN |FAT4BRAIN]]
| width="100" align="center" |[[File:FAT4BRAIN logo.png|80px|link=https://wiki.oroboros.at/index.php/FAT4BRAIN |FAT4BRAIN]]
Line 25: Line 23:
:from the O2k-Network »[[LV Riga Liepins E]]«
:from the O2k-Network »[[LV Riga Liepins E]]«
|}
|}
----
*'''Aug- 25 Fr'''
*'''Aug- 25 Fr'''
----
----

Revision as of 08:56, 21 August 2023

Gentle Science
Oroboros declares solidarity against the Russian aggression-war in Ukraine and against all aggression-wars worldwide. -  »More details
A future for Ukraine is the future of its science
2023 Week 34
  • Aug- 21 Mo

  • Aug- 22 Tu
MitoPedia
Are pyruvate, glutamate, and malate substrates of Complex I?

No, NADH is a Complex I substrate. However, pyruvate, glutamate and malate are used in high-resolution respirometry as substrates for mitochondrial dehydrogenases to generate NADH in the mitochondrial matrix because NADH cannot cross the mitochondrial inner membrane.
- »NADH electron transfer-pathway state« and »Complex I« 
- communicated by »Cardoso Luiza« and »Grings Mateus«


  • Aug- 23 We

  • Aug- 24 Th
FAT4BRAIN "Understanding acylcarnitine metabolic and signaling pathways provides a better rationale for selecting targets for therapeutic interventions."
  • Dambrova M, Makrecka-Kuka M, Kuka J, Vilskersts R, Nordberg D, Attwood MM, Smesny S, Sen ZD, Guo AC, Oler E, Tian S, Zheng J, Wishart DS, Liepinsh E, Schioth HB. (2022) Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials. »Bioblast link«
from the O2k-Network »LV Riga Liepins E«

  • Aug- 25 Fr